Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 2/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | BRD4 | O60885 | 2/20 | 0.45 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.45 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.45 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.45 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.45 |
| ▸ | MAOB | P27338 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2343079 | 0.83 | MAOB (0.59) | HPGDSMN1; SMN2NPC1RAB9AKDM4E | |
| SCHEMBL487915 | 0.80 | FOLH1 (0.48) | HPGDSMN1; SMN2NPC1RAB9AKDM4E | |
| SCHEMBL793724 | 0.79 | MEN1 (0.65) | HPGDSMN1; SMN2NPC1RAB9AKDM4E | |
| SCHEMBL28236202 | 0.79 | KDM4E (0.53) | HPGDSMN1; SMN2NPC1RAB9AKDM4E | |
| Hydrochloric Acid SCHEMBL514496 | 0.78 | MEN1 (0.63) | HPGDSMN1; SMN2NPC1RAB9AKDM4E | |
| SCHEMBL14660694 | 0.78 | MEN1 (0.63) | HPGDSMN1; SMN2NPC1RAB9AKDM4E | |
| SCHEMBL9680615 | 0.78 | HPGD (0.58) | HPGDSMN1; SMN2NPC1RAB9AKDM4E | |
| SCHEMBL22555974 | 0.77 | HPGD (0.54) | HPGDSMN1; SMN2NPC1RAB9AKDM4E | |
| SCHEMBL2338199 | 0.77 | HPGD (0.76) | HPGDSMN1; SMN2NPC1RAB9AKDM4E | |
| SCHEMBL514495 | 0.77 | GLRA1 (0.65) | HPGDSMN1; SMN2NPC1RAB9AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8513395-B2 | Method for the synthesis of anthocyanins | BIOSYNTH AS (NO) | 2013-08-20 | — | — | US | disclosed |
| US-8513395-B2 | Method for the synthesis of anthocyanins | BIOSYNTH AS (NO) | 2013-08-20 | — | — | US | disclosed |
| EP-1891086-B1 | METHOD FOR THE SYNTHESIS OF ANTHOCYANINS | BIOSYNTH AS (NO) | 2011-08-24 | — | — | EP | disclosed |
| US-20090111975-A1 | METHOD FOR THE SYNTHESIS OF ANTHOCYANINS | BIOSYNTH AS (NO) | 2009-04-30 | — | — | US | disclosed |
| US-20090111975-A1 | METHOD FOR THE SYNTHESIS OF ANTHOCYANINS | BIOSYNTH AS (NO) | 2009-04-30 | — | — | US | disclosed |
| EP-1891086-A1 | METHOD FOR THE SYNTHESIS OF ANTHOCYANINS | Biosynth AS (NO) | 2008-02-27 | — | — | EP | disclosed |
| WO-2006134352-A1 | METHOD FOR THE SYNTHESIS OF ANTHOCYANINS | BIOSYNTH AS (NO) | 2006-12-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090111975-A1 | METHOD FOR THE SYNTHESIS OF ANTHOCYANINS | POR, SPR, G6PD | HPGD 1028/4885SMN1; SMN2 4251/4885NPC1 1527/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.